NCT04316221

Brief Summary

The specific aims of this study are: In a randomized controlled trial, the investigators will evaluate the impact of daily egg consumption during the complementary feeding period in addition to the local standard of nutrition care (i.e., intervention group), compared to the local standard of nutrition care alone (i.e., control group) on the following outcomes, in infants that are \~6-month old at baseline:

  1. 1.Child development, as measured by global development scores (primary outcome)
  2. 2.Growth, as measured by anthropometrics (secondary outcome)
  3. 3.Diet quality, as measured by the World Health Organization infant and young child feeding indicators (secondary outcome)

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,200

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Apr 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 16, 2020

Completed
4 days until next milestone

First Posted

Study publicly available on registry

March 20, 2020

Completed
1 year until next milestone

Study Start

First participant enrolled

April 1, 2021

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2023

Completed
Last Updated

March 13, 2026

Status Verified

March 1, 2026

Enrollment Period

2.5 years

First QC Date

March 16, 2020

Last Update Submit

March 12, 2026

Conditions

Keywords

Eggsnutritiongrowth stuntinginfant development

Outcome Measures

Primary Outcomes (2)

  • Caregiver Reported Child Development Instruments (CREDI)

    The long form CREDI uses caregiver report and captures five domains: motor, language, cognition, social-emotional, and mental health. The CREDI is designed specifically to measure normal development within populations and has been tested in high, middle and low income countries The CREDI included a Guatemalan sample in the validation

    6 months

  • Guide for Monitoring Child Development (GMCD)

    The GMCD has been used in low- and middle-income countries in children ages 0-24 months and focuses on seven areas: expressive language, receptive language, fine motor, gross motor, relating, play, and self-help.

    6 months

Secondary Outcomes (5)

  • changes in infant hemoglobin

    6 months

  • weight-for-age

    6 months

  • length-for-age

    6 months

  • Head circumference

    6 months

  • Infant diet quality

    6 months

Study Arms (2)

Control

ACTIVE COMPARATOR

The standard of nutrition care in Guatemala includes the following clinical care, as determined to be necessary by the MHA medical and nutrition teams: frequent growth monitoring, general nutrition education, parasite treatment, and multiple micronutrient supplementation.

Other: Standar of care

Intervention

EXPERIMENTAL

The intervention group will receive an intervention to promote daily egg consumption for a six month period, in addition to the local standard of nutrition care. Specifically, intervention group participants will be provided with enough eggs for the infant to consume one egg, daily, for six months, and also with education on preparation and consumption of eggs.

Dietary Supplement: Eggs plus standard of care

Interventions

Eggs plus standard of careDIETARY_SUPPLEMENT

Eggs will be secured locally and delivered to families weekly.

Intervention

frequent growth monitoring, general nutrition education, parasite treatment, and multiple micronutrient supplementation.

Control

Eligibility Criteria

Age6 Months - 9 Months
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Infants who are 6.0-9.0 months of age at baseline
  • At least one caregiver willing to provide oral informed consent
  • Planned residence in the study area for approximately the next 18 months
  • Singleton birth

You may not qualify if:

  • Infants with moderate to severe acute malnutrition (weight-for-length z-score \< -2)
  • Infants with severe anemia (Hgb \<7 g/dL per WHO guidelines, with adjustments for altitude as necessary)
  • Infants with a chronic medical condition that affects growth (e.g., congenital heart disease, genetic condition) as determined by the MHA staff physician
  • Infants whose caregivers have cognitive or other impairments that prevent them from being able to provide informed consent or to reliably provide information required for the developmental assessments
  • Infants with a known egg allergy
  • Infants with recalcitrant, moderate-to-severe atopic dermatitis
  • Infants with a history of anaphylaxis or serious allergic reaction to any substance requiring emergency medical care
  • Concurrent participation in any other clinical trial

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Wuqu' Kawoq/Maya Health Alliance

Tecpán Guatemala, Departamento de Chimaltenango, Guatemala

Location

MeSH Terms

Interventions

EggsStandard of Care

Intervention Hierarchy (Ancestors)

FoodDiet, Food, and NutritionPhysiological PhenomenaFood and BeveragesQuality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: This is a randomized controlled trial involving children ages \~6 to 12 months from communities in central Guatemala within Wuqu' Kawoq's catchment area individually randomized to either the intervention or control group.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 16, 2020

First Posted

March 20, 2020

Study Start

April 1, 2021

Primary Completion

September 30, 2023

Study Completion

September 30, 2023

Last Updated

March 13, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations